Oral Weekly Ibandronate Prevents Bone Loss in Postmenopausal Women

Journal of Internal Medicine - United Kingdom
doi 10.1046/j.1365-2796.2003.01174.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Patient Satisfaction in Postmenopausal Women Treated With a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate

Journal of Women's Health
Medicine
2009English

Pharmacotherapy of Bone Loss in Postmenopausal Women: Focus on Denosumab

Clinical Medicine. Therapeutics
2009English

Phyto-Oestrogen Excretion and Rate of Bone Loss in Postmenopausal Women

European Journal of Clinical Nutrition
MedicineNutritionDietetics
1998English

Study on Bone Loss of Pre- And Postmenopausal Women in AMHTS

Japanese journal of MHTS
1997English

Association Between Tooth Loss and Bone Mineral Density in Brazilian Postmenopausal Women

Journal of Clinical Medicine Research
2011English

Bone Mineral Density in Postmenopausal Women as Determined by Prior Oral Contraceptive Use.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1993English

Emerging Evidence on the Link Between Depressive Symptoms and Bone Loss in Postmenopausal Women

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2017English

Changes in Cytokines, Biomarkers of Bone Turnover and Hormones Are Associated With Bone Loss in Postmenopausal Indian Women

International Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2012English

Profile of Changes in Bone Turnover Markers During Once-Weekly Teriparatide Administration for 24 Weeks in Postmenopausal Women With Osteoporosis

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy